Order Article Reprints

Ávila M, Prado MdC, Romero R, Córdova R, Rigo MdC, Trejo M, Mora C, Paniagua R, for the Mexican Nephrology Collaborative Study Group. Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis. Biomolecules. 2022; 12(4):551. https://doi.org/10.3390/biom12040551

Ávila, Marcela, Ma. del Carmen Prado, Renata Romero, Ricardo Córdova, Ma. del Carmen Rigo, Miguel Trejo, Carmen Mora, Ramón Paniagua, and for the Mexican Nephrology Collaborative Study Group. 2022. "Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis" Biomolecules 12, no. 4: 551. https://doi.org/10.3390/biom12040551

Ávila, M., Prado, M. d. C., Romero, R., Córdova, R., Rigo, M. d. C., Trejo, M., Mora, C., Paniagua, R., & for the Mexican Nephrology Collaborative Study Group. (2022). Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis. Biomolecules, 12(4), 551. https://doi.org/10.3390/biom12040551